We are live on ! Find out more
BA

Boston Advisors Portfolio holdings

AUM $1.91B
1-Year Est. Return 6.26%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+6.26%
3 Year Est. Return
+73.82%
5 Year Est. Return
+112.87%
10 Year Est. Return
AUM
$4.05B
AUM Growth
+$38.8M
Cap. Flow
-$116M
Cap. Flow %
-2.87%
Top 10 Hldgs %
18.39%
Holding
733
New
60
Increased
226
Reduced
298
Closed
60

Top Sells

Rank Stock Value
1
CLX icon
Clorox
CLX
+$24.7M
2
DIS icon
Walt Disney
DIS
+$19.9M
3
TGT icon
Target
TGT
+$19M
4
DRI icon
Darden Restaurants
DRI
+$18.6M
5
CI icon
Cigna
CI
+$17.6M

Sector Composition

Rank Sector Weight
1 Healthcare 17.77%
2 Technology 14.35%
3 Financials 11.2%
4 Industrials 10.03%
5 Communication Services 9.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UHS icon
226
Universal Health Services
UHS
$10.1B
$4.1M 0.1%
33,271
-1,083
-3% -$137K
EQNR icon
227
Equinor
EQNR
$97.2B
$4.08M 0.1%
242,601
-5,939
-2% -$96.5K
MCHB
228
Mechanics Bancorp
MCHB
$3.67B
$4.06M 0.1%
+162,120
New +$3.82M
MUB icon
229
iShares National Muni Bond ETF
MUB
$45.1B
$4M 0.1%
35,474
+9,403
+36% +$1.07M
TXN icon
230
Texas Instruments
TXN
$252B
$3.97M 0.1%
56,532
-10,207
-15% -$696K
UGI icon
231
UGI
UGI
$7.76B
$3.95M 0.1%
87,387
-1,747
-2% -$79.7K
CATY icon
232
Cathay General Bancorp
CATY
$4.21B
$3.93M 0.1%
127,735
-14,895
-10% -$452K
PFC
233
DELISTED
Premier Financial Corp. Common Stock
PFC
$3.79M 0.09%
169,862
-40,330
-19% -$868K
PEP icon
234
PepsiCo
PEP
$191B
$3.78M 0.09%
34,711
-132
-0.4% -$14.2K
VWO icon
235
Vanguard FTSE Emerging Markets ETF
VWO
$120B
$3.76M 0.09%
99,875
+42,657
+75% +$1.59M
SYK icon
236
Stryker
SYK
$125B
$3.73M 0.09%
32,070
-120
-0.4% -$14K
LXP icon
237
LXP Industrial Trust
LXP
$3.57B
$3.63M 0.09%
+70,390
New +$3.71M
NWL icon
238
Newell Brands
NWL
$2.45B
$3.62M 0.09%
68,645
-1,243
-2% -$64.3K
SRCE icon
239
1st Source
SRCE
$2.16B
$3.56M 0.09%
99,655
-11,735
-11% -$402K
RYAM icon
240
Rayonier Advanced Materials
RYAM
$599M
$3.41M 0.08%
255,020
-31,525
-11% -$407K
VFC icon
241
VF Corp
VFC
$5.67B
$3.4M 0.08%
64,453
-637
-1% -$36.8K
FRME icon
242
First Merchants
FRME
$2.69B
$3.36M 0.08%
125,630
-14,680
-10% -$388K
APLP
243
DELISTED
Archrock Partners, L.P. Common Units representing Limited Partner Interests
APLP
$3.36M 0.08%
+228,070
New +$3.27M
INVX
244
Innovex International
INVX
$1.94B
$3.33M 0.08%
59,785
-8,125
-12% -$453K
HA
245
DELISTED
Hawaiian Holdings, Inc.
HA
$3.27M 0.08%
67,186
-8,680
-11% -$394K
DCOM
246
DELISTED
Dime Community Bancshares
DCOM
$3.14M 0.08%
187,340
-22,020
-11% -$382K
ALL icon
247
Allstate
ALL
$68.5B
$3.13M 0.08%
45,248
+2,903
+7% +$200K
ORCL icon
248
Oracle
ORCL
$369B
$3.08M 0.08%
78,340
+3,188
+4% +$130K
CB icon
249
Chubb
CB
$136B
$3.07M 0.08%
24,461
-1,400
-5% -$178K
ABT icon
250
Abbott
ABT
$182B
$3.05M 0.08%
72,056
-296
-0.4% -$12.7K

Similar funds

Boston Advisors's Q3 2016 Portfolio in Review

As of Q3 2016, Boston Advisors held 733 positions worth $4.05B, up 0.97% from $4.01B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Boston Advisors's Q3 2016 filing shows 60 new, 226 increased, 298 reduced and 60 closed positions. Its largest new stake was Vertex Pharmaceuticals: 188,245 shares worth $16.4M. The largest sale was Clorox, an estimated $24.7M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Technology and Financials.

  • Boston Advisors's largest Q3 2016 buy was Vertex Pharmaceuticals: 188,245 shares worth $16.4M.
  • Boston Advisors added most to AbbVie in Q3 2016, an estimated $27.2M increase.
  • Boston Advisors's biggest Q3 2016 reduction was Clorox, cutting an estimated $24.7M.
  • Boston Advisors fully exited Cadence Design Systems in Q3 2016, selling an estimated $14.4M.
  • Boston Advisors's ten largest holdings make up 18% of its $4.05B portfolio in Q3 2016.
  • Boston Advisors opened 60 new positions and closed 60 in Q3 2016.
  • Boston Advisors's portfolio value rose 0.97% quarter-over-quarter to $4.05B.

Based on Boston Advisors's 13F filing for Q3 2016, filed 25 Oct 2016.